Connection

Sergio Bernardini to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Sergio Bernardini has written about Antibodies, Viral.
Sergio Bernardini
Connection Strength
0.287
Antibodies, Viral
  1. Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection. Int Immunopharmacol. 2021 Oct; 99:108013.
    View in: PubMed
    Score: 0.091
  2. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay. J Med Virol. 2021 04; 93(4):2523-2528.
    View in: PubMed
    Score: 0.088
  3. Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus. Int Immunopharmacol. 2021 Mar; 92:107330.
    View in: PubMed
    Score: 0.087
  4. Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves. Immunol Invest. 2022 Feb; 51(2):233-245.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.